Perez-Chada, Lourdes Maria http://orcid.org/0000-0001-7724-7309
Cohen, Jeffrey M.
Gottlieb, Alice Bendix
Duffin, Kristina Callis
Garg, Amit
Latella, John
Armstrong, April Wang
Ogdie, Alexis http://orcid.org/0000-0002-4639-0775
Merola, Joseph Frank http://orcid.org/0000-0001-6514-4353
Article History
Received: 30 March 2018
Revised: 17 July 2018
Accepted: 11 August 2018
First Online: 25 August 2018
Compliance with ethical standards
:
: Dr. Gottlieb is an advisor/consultant for Janssen Inc.; Celgene Corp., Bristol Myers Squibb Co., Beiersdorf, Inc., Abbvie, UCB, Novartis, Incyte, Pfizer, Lilly, Xenoport, Development Crescendo Bioscience, Aclaris, Amicus, Reddy Labs, Valeant, Dermira, Allergan, CSL Behring, Merck, Sun Pharmaceutical Industries. Also, she received research/educational grants from Janssen, Incyte. Dr. Duffin has been a consultant and/or investigator for Amgen, Janssen, Lilly, Novartis, Celgene, Pfizer; Bristol-Myers Squibb Co. Dr. Garg served on the advisory board of Abbvie, Janssen, and Pfizer receiving honoraria. Also, he received research/educational grants from AbbVie and Merck. Dr. Armstrong has served as investigator, advisor and/or consultant to AbbVie, Janssen, Novartis, Lilly, Regeneron, Sanofi, Science 37, Modernizing Medicine, and Valeant. Dr. Merola has served as an advisor/consultant for Biogen IDEC, AbbVie, Amgen, Eli Lilly, Novartis, Pfizer, Janssen, UCB, Kiniksa, Momenta and Mallinckrodt. He has been a speaker for AbbVie and Eli Lilly, and an investigator for Biogen IDEC, Amgen, Pfizer and Boehringer Ingelheim. Dr. Ogdie served as a consultant for Bristol-Myers Squibb, Lilly, Novartis, Pfizer, and Takeda and has received grant funding to the University of Pennsylvania from Pfizer (co-investigator) and Novartis. John Latella has served as Patient Consultant for Boehringer Ingelheim, and Patient Advocate for GfK. Dr. Perez-Chada has received research funding from “RADLA Scholarship 2010”. The other authors have no disclosures.
: Evaluation by an ethical board was deemed exempt given the nature of a consensus meeting. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Process to obtain informed consent was deemed exempt given the nature of a consensus meeting.